Upload dinhtuong
View 213
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
Board of Directors Meeting · 2017-02-02 · Q3 FY-15 Q4 FY-15 Q1 FY-16 Q2 FY-16 Q3 FY-16 Q4 FY-16 Q1 FY-17 Q2 FY-17 2009 ... 2015 •Design-Build construction cost: $18.4M Access
Investor Presentation – Q3 FY 2014
FINANCIAL RESULTS Q3 FY 2013 · (Rs. In Millions) 13 Non-Performing Assets & Bad Debts written off Q3 FY 2013 Q2 FY 2013 Q1 FY 2013 Q3 FY 2012 FY 2012 Rs. RS. Rs. Rs. Rs. Gross Non-Performing
Forward Work Plan - dpti.sa.gov.au · Program Project Estimated Project Value Status FY 2018-19 FY 2019-20 FY 2020-21 FY 2021-22 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Addressing
Q3 FY’2013- Presentation 28th Jan’2013 - Transformer India · 2013-01-28 · Financials –Standalone Particulars s cs) Q3 FY’2013 Q3 FY’2012 9Month FY’ 2013 9Month FY’
Result Update: Q3 FY 12
“Aurobindo Pharma Limited’s Q3 FY2013-14 Unaudited ... · “Aurobindo Pharma Limited’s Q3 FY2013-14 Unaudited Earnings Conference Call” February 7, 2014 MANAGEMENT: ... Pharma
Q3 2019 Financial Results Supplementary Presentation ... 2019...Q3 2018 Q3 2019 Q3 2018 Q3 2019 Q3 2018 Q3 2019 Q3 2018 Q3 2019 1.67 0.69 1.16 1.65 2.85 FY 2015 FY 2016 FY 2017 FY
Q3 FY 2005-06 Results
Unaudited Financial Results Q3 FY 2018-19 January 31, 2019 · Business Update 4 9M FY 18-19 9M FY 17-18 YoY Growth [%] Balance Sheet 128,750 123,235 4.5% Loan Assets 124,271 106,971
Griffon Q3 FY 2021
Hindalcohindalco.com/upload/pdf/Q3FY17_Investor_Presentation.pdfInvestor Presentation –Q3 FY17 February 13, 2017. ... (Q3 FY 17 vs Q3 FY 16) 9. Q3 FY17- A strong operating performance
FY Q3 2021 Earnings Supplement - static.seekingalpha.com
9M & Q3 FY 2018-19 - SAIL · Rs. Crore (INDAS Compliant figures) 9MFY19 9MFY18 Q3 FY 19 Q2 FY 19 Q3 FY 18 Sales 47944 41486 15660 16541 15190 EBITDA 7806 2528 2653 2479 1560 Depreciation
PZ CUSSONS NIGERIA PLC Q3, 2019/20 UNAUDITED FINANCIAL
Q3 FY 2021 Results & Outlook
Earnings Call–Q3’ FY19 - STL · Q1 FY 2019 Q2 FY 2019 Q3 FY 2019 208 238 252 279 304 Q3 FY 2018 Q4 FY 2018 Q3 FY 2019 Q1 FY 2019 Q2 FY 2019 90 112 121 131 146 Q3 FY 2018 Q3 FY
Q3 FY 2021 SUPPLEMENTAL SLIDES
Magma Investor Presentation Q3 Fy 12
Presentation Q3 FY 13 14
March 16, ROTH 28th Annual Conference 2016€¦ · FY 2012 FY 2013 FY 2014 FY 2015 Q3 FY 2016 TTM Distribution Sales $5.6 $4.6 $4.3 $3.1 $2.7 FY 2012 FY 2013 FY 2014 FY 2015 Q3 FY
Q3 FY’19 Investor Presentation · Q3 FY’19 Q3 FY’18 Y/Y Change Billings(1) $821.9Mn $724.7Mn 13.4% Revenue $726.6Mn $567.7Mn 28.0% Gross margin %(2) 76.5% 76.2% 30 bps Operating
MAY 30, 2019 ASC 606 TRANSITION MATERIALS...TOTAL REVENUE IMPACT - FY 2018 & FY 2019 Note: All amounts are unaudited and may not sum due to rounding. YoY Growth Q3 FY19 Q4 FY19 Q1
Q3 Financial Results - Transcat · 2019/2/5 · Q3 FY 2018 Q3 FY 2019 Q3 Distribution Segment $71.8 $63.0 $72.8 $77.7 $77.2 $51.8 $59.2 $71.1 $77.4 $81.7 FY 2015 FY 2016 FY 2017
LGIP Q3 FY 2012
Q1 FY2021 Earnings · 2020-06-02 · Q1 FY’19 Q2 FY’19 Q3 FY’19 Q4 FY’19 Q1 FY’20 Q2 FY’20 Q3 FY’20 Q4 FY’20 Q1 FY’21 Q2 FY’21 Guidance Quarterly subscription
Sharing the Joy of Food Investor Update Q3 FY 2016 - Future Consumer · Particulars (In ₹ mn) Q3 (FY 16) Q2 (FY 16) Q3 (FY 15) FY 15 Total Operating Income 5,193 4,476 3,700 13,166
Unaudited Interim Financial Statements Q3 2017 Unilever
FY 2021 Q3 - Dallas
Business review-q3-fy-13